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Abstract
The Global Programme to Eliminate Lymphatic Filariasis (LF) aims to eliminate the dis-
ease as a public health problem by 2020 by conducting mass drug administration (MDA)
and controlling morbidity. Once elimination targets have been reached, surveillance is crit-
ical for ensuring that programmatic gains are sustained, and challenges include timely
identification of residual areas of transmission. WHO guidelines encourage cost-efficient
surveillance, such as integration with other population-based surveys. In American
Samoa, where LF is caused by Wuchereria bancrofti, and Aedes polynesiensis is the main
vector, the LF elimination program has made significant progress. Seven rounds of MDA
(albendazole and diethycarbamazine) were completed from 2000 to 2006, and Transmis-
sion Assessment Surveys were passed in 2010/2011 and 2015. However, a seropreva-
lence study using an adult serum bank collected in 2010 detected two potential residual
foci of transmission, with Og4C3 antigen (Ag) prevalence of 30.8% and 15.6%. We con-
ducted a follow up study in 2014 to verify if transmission was truly occurring by comparing
seroprevalence between residents of suspected hotspots and residents of other villages.
In adults from non-hotspot villages (N = 602), seroprevalence of Ag (ICT or Og4C3), Bm14
antibody (Ab) and Wb123 Ab were 1.2% (95% CI 0.6–2.6%), 9.6% (95% CI 7.5%-12.3%),
and 10.5% (95% CI 7.6–14.3%), respectively. Comparatively, adult residents of Fagali’i (N
= 38) had significantly higher seroprevalence of Ag (26.9%, 95% CI 17.3–39.4%), Bm14
Ab (43.4%, 95% CI 32.4–55.0%), and Wb123 Ab 55.2% (95% CI 39.6–69.8%). Adult resi-
dents of Ili’ili/Vaitogi/Futiga (N = 113) also had higher prevalence of Ag and Ab, but differ-
ences were not statistically significant. The presence of transmission was demonstrated
by 1.1% Ag prevalence (95% CI 0.2% to 3.1%) in 283 children aged 7–13 years who lived
in one of the suspected hotspots; and microfilaraemia in four individuals, all of whom lived
in the suspected hotspots, including a 9 year old child. Our results provide field evidence
that integrating LF surveillance with other surveys is effective and feasible for identifying
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potential hotspots, and conducting surveillance at worksites provides an efficient method
of sampling large populations of adults.
Author summary
Lymphatic filariasis (LF) is caused by infection with filarial worms that are transmitted by
mosquito bites. The Global Programme to Eliminate Lymphatic Filariasis aims to elimi-
nate the disease as a public health problem by 2020. Once elimination targets have been
reached, cost-effective surveillance strategies are required to ensure that any areas of
ongoing transmission or resurgence are quickly identified and managed. Potential options
include the integration of LF surveillance with other public health activities. In American
Samoa, blood samples collected in 2010 for a research project on a different disease (lepto-
spirosis) were used to test for evidence of LF infection, and the study found two possible
areas of ongoing transmission. We conducted a follow up study in 2014 to verify whether
LF infection was truly occurring in these two areas, and found that infection rates in both
areas were significantly higher compared to other parts of American Samoa. Our results
therefore provide field evidence that integrating LF surveillance activities with other pop-
ulation-based surveys are potentially effective and feasible, and provide a cost-effective
method for identifying residual areas of transmission.
Introduction
Lymphatic filariasis (LF) is a mosquito-borne parasitic infection caused by Wuchereria or Bru-
gia species of helminths. Mosquito vectors vary between countries and regions, and include
Aedes, Anopheles, Culex and Mansonia species. Globally, it is estimated that 68 million people
are affected, comprising approximately 36 million microfilaraemic persons and 36 million
with disabling complications such as severe lymphedema, including elephantiasis and scrotal
hydroceles [1]. The Global Programme to Eliminate LF (GPELF) was launched by the World
Health Organization in 2000, with the aim of eliminating the disease as a public health prob-
lem by 2020. The program consists of two components: i) to interrupt transmission through
mass drug administration (MDA) and ii) to control morbidity and disability of affected popu-
lations [2]. As part of GPELF, the Pacific Programme to Eliminate LF (PacELF) was formed in
1999 to focus on 22 Pacific Island Countries and Territories (PICTs). PacELF focused on coor-
dinating the elimination efforts in the PICTs, which include >3000 islands and 8.6 million
people [3,4].
Since 2000, the GPELF has made impressive progress globally, with a total of 6.2 billion
treatments delivered to>820 million people [2]. Once elimination targets have been reached,
effective monitoring and surveillance are critical for ensuring that programmatic gains are sus-
tained in the long-term. The World Health Organization and GPELF have identified some key
operational challenges in post-MDA surveillance, including i) timely identification of residual
areas of high-prevalence and/or resurgence, ii) strategies for managing these high risk areas,
and iii) development of cost-effective surveillance strategies [5,6].
In American Samoa, a group of remote islands in the South Pacific, LF is caused by the
diurnally sub-periodic W. bancrofti, and the main mosquito vector responsible for transmis-
sion is the highly efficient day-biting Ae. polynesiensis. Other vectors include Ae. samoanus
(night-biting), Ae. tutuilae (night-biting), and Ae. upolensis (day-biting) [7–10]. Two rounds of
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MDA in 1963 and 1965 reduced microfilaria (Mf) prevalence from ~20% to<2% [4,11,12].
Unfortunately, transmission was not successfully interrupted, and antigen prevalence mea-
sured by rapid immunochromatographic test (ICT) had risen to 16.5% (N = 3018) when the
PacELF baseline survey was conducted in 1999. Since then, American Samoa has made signifi-
cant progress towards LF elimination. After seven rounds of MDA from 2000–2006, antigen
prevalence dropped to 2.3% (N = 1881) in a community cluster survey in 2007 [13–15]. How-
ever, the results of the 2007 survey did not meet PacELF’s criteria for stopping MDA (<1%
antigenaemia, upper 95% CI <2%), and an additional round of MDA was recommended, but
no further effective rounds of MDA were successfully completed after this time [15].
The WHO currently recommends post-MDA surveillance using transmission assessment
surveys (TAS), which use critical cut-off values of numbers of antigen-positive children aged
6–7 years to determine whether transmission has been interrupted in defined evaluation units
[16]. In areas where W. bancrofti is endemic and Aedes is the principal vector, the target
threshold for post-MDA transmission assessment surveys (TAS) is <1% antigenaemia [16].
American Samoa passed TAS-1 in 2011–2012 [17] and TAS-2 in 2015 [18], but recent human
seroprevalence studies and molecular xenomonitoring studies of mosquitoes identified epide-
miological and entomological evidence of ongoing LF transmission [10,19,20].
As prevalence drops to very low levels in the end stages of elimination programs, not only
will it become more challenging to detect any residual hotspots of ongoing transmission, but
funding and resources for programmatic activities will also generally be reduced. The current
WHO guidelines therefore encourage cost-efficient methods for post-MDA surveillance,
including the integration of LF surveillance activities with other population-based surveys, and
opportunistic screening of large groups (e.g. military recruits, hospital patients, and blood
donors) for microfilaraemia, antigenaemia, or antibodies [16]. For example, in Togo [21] and
Vanuatu [22], nationwide LF surveillance has been successfully conducted by screening blood
smears collected for malaria diagnosis. However, there is currently little evidence about the
effectiveness of these strategies for identifying infected persons in the post-MDA setting.
Lau et al previously reported a study of the seroprevalence and spatial epidemiology of LF
in American Samoa after successful MDA [19]. The study used a serum bank collected from
adults (aged18 years) for a leptospirosis study in 2010 [23], four years after the last effective
round of MDA. The study found epidemiological evidence of possible residual foci of Og4C3
Ag-positive people in two localised areas, with an average cluster size of ~1.5 km. One cluster
was found in the very small village of Fagali’i, where the seroprevalence of Og4C3 Ag was
30.8% (95% CI 9.1–61.4%). Another cluster spanned the contiguous villages of Ili’ili, Vaitogi,
and Futiga, where overall Og4C3 Ag prevalence was 15.6% (95% CI 5.3–32.8%) (data derived
from [19]). However, the findings were not definitive because information on microfilaraemia
was not available; the study was conducted using a pre-existing serum bank and the findings
were based entirely on serological markers. In this paper, we report results of a follow up study
in 2014 to confirm whether there was indeed ongoing transmission and/or higher infection
rates in the two suspected ‘hotspot areas’ identified from the previous work. If ongoing trans-
mission was truly occurring in these two suspected hotspot areas, our findings would provide
field evidence to support WHO’s recommendations for integrating LF surveillance activities
with other population-based surveys, including those that only include adults [16].
Materials and methods
Ethics statement
Ethics approvals were granted by the American Samoa Institutional Review Board, and the
Human Research Ethics Committees at James Cook University (H5519) and The University of
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Queensland (2014000409). The study was conducted in collaboration with the American
Samoa Department of Health, and official permission for village visits was sought from the
Department of Samoan Affairs and village chiefs and/or mayors. Verbal and written informa-
tion were provided to all participants (or their parent or guardian) in Samoan or English
according to the participant’s preference. Signed informed consent forms were obtained from
all participants, or their parent or guardian if under 18 years of age.
Study location and setting
American Samoa is a United States Territory in the South Pacific, consisting of a group of
small tropical islands with a total population of 55,519 living in ~70 villages (average popula-
tion ~800 per village) at the 2010 census [24]. Over 90% of the population live on the main
island of Tutuila, and the remainder on the adjacent island of Aunu’u and the remote Manu’a
group of islands. American Samoa has a tropical climate and is one of the wettest inhabited
places in the world, with islands that include mountains, valleys, tropical rainforests, wetlands,
fringing reefs, and lagoons.
Sampling design
Field data were collected from American Samoa in 2014 from the following groups of
participants:
1. Adult workers (aged15 years) recruited from:
a. A Department of Health clinic where workers attend for fitness-for-work medical
examinations
b. Starkist tuna cannery (the largest private employer in the territory)
2. Community members (aged2 years) from the two suspected hotspot areas identified by
the previous study [19]:
a. The contiguous villages of Ili’ili, Vaitogi and Futiga, with a combined population of
5,877 [24]
b. Fagali’i, a very small village on the far western end of Tutuila, with a population of 247
[24]
3. School children (Grades 3 to 8, aged 7 to 13 years) from the large elementary school in Ili’ili.
This school was included in the study because it was the only school where ICT-positive
children were identified in the 2011/2012 TAS-1 [17], and also located in Ili’ili, within one
of the suspected hotspot areas. The school survey provided a convenient and cost-effective
method of sampling a large number of children who lived in Ili’ili, Vaitogi, and Futiga.
Grades 1 and 2 children were not included in our 2014 study because they were to be tested
in the 2015 TAS-2 a few months after our survey. There were no other elementary schools
in Ili’ili, and no schools located in Fagali’i, the other suspected hotspot area.
Adult workers and village residents were recruited by convenience sampling because proba-
bility-based sampling was not logistically possible with the available budget and resources. The
field team was stationed at the weekly Department of Health clinic from May to December
2014 (~4 hours per visit), and invited all clinic attendees to participate. Visits to the tuna can-
nery, villages, and school were conducted over a 3-week period in October and November
2014. The team visited the tuna cannery on four occasions (~4 hours per visit), and all employ-
ees on duty were invited to participate. For visits to the suspected hotspot areas, permissions
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were sought from village chiefs and mayors, who informed residents of the team’s pre-
arranged visits. During the three village visits to Ili’ili/Vaitogi/Futiga, and one village visit to
Fagali’i (~4 hours per visit), the field team was positioned in a prominent and central part of
the community, and all residents were invited to participate. All children in Grades 3 to 7 who
attended the elementary school in Ili’ili were invited to participate; information sheets and
consent forms were distributed to parents and guardians about one week beforehand, and all
children who returned valid consent forms were tested.
Collection of samples and data
The following samples and data were collected from each participant:
1. Blood samples, collected by trained phlebotomists under sterile conditions:
• Venous samples (~5mL) were collected from adult workers and community members
• Finger prick samples were collected from school children into heparinised capillary tubes
(100 μL) and whole blood collected onto TropBio filter papers (10 μL per ear, max 6 ears
per participant). The filter papers were allowed to dry thoroughly and then placed in indi-
vidual sealed plastic bags.
2. Questionnaire data, using standard questionnaires administered by bilingual research assis-
tants. Information on demographics, country of birth or years lived in American Samoa,
and current village of residence were collected from all participants. Questions for commu-
nity members and adult workers also included occupation, years lived in American Samoa,
history of taking MDA, and previous diagnosis of lymphatic filariasis (by a doctor or other
health care worker).
3. Household location data, using detailed village maps generated from high-resolution geo-
graphic information system (GIS) data (except for school children where only the village of
residence was recorded).
Data on population demographics were sourced from the 2014 American Samoa Statistical
Year Book [24], and high-resolution GIS data were provided by the American Samoa GIS User
Group [25].
Serological analysis and microscopic examination for microfilaria
Venous or fingerprick blood samples were tested for filarial antigen immediately after collec-
tion using the Alere BinaxNOW Filariasis immunochromatographic test (ICT). If an ICT was
positive, the result was confirmed by repeating the test, and two Mf slides were prepared, each
with 60 μL of blood in 3 lines of 20 μL each per slide. Once thoroughly dried, slides were
dehaemoglobinized, fixed with methanol and stained with 2% Giemsa stain for 50 minutes
according to WHO guidelines [16] and examined at 100x magnification. Mf densities in 60 μL
were determined by counting all Mf on each slide. Each set of Mf slides were read blindly by
two or three experienced parasitologists, one at James Cook University Cairns (PG) and the
other(s) at the LBJ Tropical Medical Centre in American Samoa and/or at James Cook Univer-
sity in Townsville, Australia. Counts were converted to Mf/mL and the final Mf density
recorded was the average of the counts reported by two or three parasitologists.
Venous blood samples were allowed to clot before centrifuging, and serum were aliquoted
and stored at -20 degrees Celsius in American Samoa. Frozen sera and dried blood spots
(DBS) were shipped to Australia for serological analysis at James Cook University, Cairns,
Australia. All samples were tested for Og4C3 Ag using the TropBio Og4C3 Filariasis Antigen
Lymphatic filariasis hotspots in American Samoa
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ELISA test (Cellabs Pty. Ltd., New South Wales, Australia) using dilutions for serum and DBS
recommended by the manufacturer. Bm14 Ab was measured using ELISA tests (CDC in house
version) as previously described [19]. For Wb123 Ab, all the village samples and 109 of the
adult worker samples were tested with in-house Wb123 ELISA as previously described [19].
The remaining 552 adult worker samples and 178 of the school children samples were tested
using the InBios Wb123 ELISA [26]. Due to insufficient volumes of blood available, 149 chil-
dren did not have Wb123 ELISA done by either method. All ELISAs used standard curves
with kit provided standards (Og4C3 Ag) or known strong positives (Bm14 Ab and Wb123
Ab). Cutoffs for positivity were aligned between the two Wb123 Ab methods.
Treatment of ICT-positive individuals
All ICT-positive individuals were treated with albendazole (400mg) and diethyl-carbamazine
(DEC) (6mg/kg) according to WHO recommended dosages, and all treatments were provided
free of charge. Children were treated with informed consent from and in the presence of at
least one parent or guardian.
Statistical analysis
The outcome measures used were positive results for ICT, Og4C3 Ag >32 units (weak posi-
tive), Og4C3 Ag >128 units (positive), ‘antigen’ (ICT and/or Og4C3 Ag >32 units), Bm14 Ab,
Wb123 Ab, and Mf. The positivity levels for Og4C3 Ag were chosen based on product infor-
mation provided by Cellabs, and a previous study in American Samoa [19].
To determine whether residents of suspected hotspot areas had higher infection rates than
residents of other villages, seroprevalence of adult workers who resided in other villages were
used as the reference group to provide estimates of infection rates in the general population.
Simple proportions were compared using Chi-squared tests or Fisher exact tests, and bino-
mial exact 95% confidence intervals. Point estimates of antigen and antibody prevalence were
calculated for residents of each of the suspected hotspot areas and adult workers who lived in
other villages. Prevalence estimates were standardised for age using American Samoa’s age dis-
tribution data from the 2014 Statistical Yearbook [24], and 95% confidence intervals calculated
using the ‘stdize’ option in the ‘proportion’ command in Stata 14, with ‘stdweights’ as the pro-
portion of the population in each age group. Statistical associations between place of residence
and presence of serological markers were quantified using univariable logistic regression
(weighted for age distribution). Because adult workers were used as the reference population,
village residents aged<15 years were excluded from the logistic regression analyses.
Data were managed using Microsoft Excel (v14, 2011) and Qualtrics (Qualtrics, Provo,
UT), an electronic platform for collecting and managing data. Stata 14 (StataCorp, College Sta-




The study included a total of 1,132 participants, comprising 172 employment clinic attendees,
498 tuna cannery workers, 125 community members from the two suspected hotspot areas,
and 337 school children who attended an elementary school in Ili’ili. The school children rep-
resented 61.6% of the total 547 students enrolled in Grades 3 to 8 at the school. Of the 337 chil-
dren, 283 (84.0%) were residents of Ili’ili/Vaitogi/Futiga, one of the suspected hotspot areas.
Children who attended the school but resided in other villages were also tested, but not
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included in the statistical analyses for residents of suspected hotspot areas because most lived
near the school and were therefore not representative of the general population of children in
American Samoa.
The participants were classified into three groups for statistical analyses:
1. Residents of Ili’ili/Vaitogi/Futiga (N = 418, aged2 years), including:
a. 66 adult workers who resided in these villages
b. 69 community members recruited from field visits to these villages
c. 283 school children who resided in these villages
2. Residents of Fagali’i (N = 58, aged2 years), including:
a. 2 adult workers who lived in this village
b. 56 community members recruited from a field visit to the village
3. Adult workers who did not live in either of the suspected hotspot areas (N = 602, aged15
years), including:
a. 151 employment clinic attendees
b. 451 cannery workers
Fig 1 shows the age distributions of residents of suspected hotspots, adult workers from
other villages, and American Samoa’s general population. A summary of the representative-
ness of each study population is shown in Table 1.
Fig 2 shows the distribution of the general population on Tutuila, the locations of the sus-
pected hotspot areas included in this study, the elementary school in Ili’ili where children were
tested, and the clinic and tuna cannery where adult workers were tested. Fig 3 shows the resi-
dential locations of all adult workers who participated in this study. Although the adult work-
ers were sampled at one clinic and one work site, they resided across 51 villages on the main
island of Tutuila and the adjacent island of Aunu’u. Considering that convenience sampling
was used in this study, the adult workers provided a reasonably representative sample of the
general adult population in terms of place of residence.
Overall, 72.3% (95% CI 61.4% to 81.6%) of adult community members and 67.6% (95% CI
63.8% to 71.3%) of adult workers reported taking MDA in the past, either in American Samoa
and/or elsewhere, while 3.6% (95% CI 0.8% to 10.2%) of adult community members and 1.3%
(95% CI 0.5% to 2.5%) of adult workers reported that a doctor or other health worker had pre-
viously diagnosed them with LF. There were no statistically significant differences in MDA
participation or LF diagnosis between adult community members and adult workers, suggest-
ing that convenience sampling did not introduce any significant participation biases towards
either group being more likely to have LF infection.
Prevalence of antigens and microfilaraemia
A total of 29 antigen-positive individuals were identified from ICT and/or Og4C3 Ag (>32
units) tests, with a female to male ratio of 1.07 and age range of 9 to 73 years. A summary of
antigen-positive results for each group is shown in Table 2.
Of the 337 school children tested, three of the 283 residents of Ili’ili/Vaitogi/Futiga were
ICT-positive (1.1%, 95% CI 0.2% to 3.1%), compared to none of the 54 who were residents of
other villages (0%, one-sided 97.5% CI 0% to 6.6%).
Lymphatic filariasis hotspots in American Samoa
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Fig 1. Age distributions of residents of suspected hotspot areas, adult workers living in other villages, and the general
population in American Samoa.
https://doi.org/10.1371/journal.pntd.0005914.g001









% (95% CI) of adults who have lived in American
Samoa since 2000a
Residents of Ili’ili, Vaitogi,
and Futiga
5,877 418 7.1% 1.33 75.7% (66.6–83.3%)
Residents of Fagali’i 247 58 23.5% 1.38 75.7% (58.8–88.2%)
Adult workers living in other
villages
37,046b 602 1.6% 1.56 70.7% (66.8–74.3%)
a Indicates persons who have lived in American Samoa since the PacELF program commenced in 2000
b Estimated total population of American Samoans aged15 years, based on Statistical Yearbook 2014 [24]
https://doi.org/10.1371/journal.pntd.0005914.t001
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Four microfilaraemic individuals were identified out of 20 available slides examined, with
Mf densities of 8, 433, 2667, and 3267 Mf/mL. These counts were the average of two or three
blind readings of the slides by different parasitologists. The Mf-positive persons were aged 9,
29, 35, and 46 years, with a female:male ratio of 1. All microfilaraemic individuals lived in the
hotspot areas; three in Fagali’i and one in Vaitogi. The age distributions of antigen-positive
and Mf-positive individuals are shown in Fig 4. Of the 15 ICT-positive people who resided in
suspected hotspot areas, Mf results were available for 14, of which 4 (28.6%) were Mf-positive.
Of the 8 ICT-positive people who resided in other villages, Mf results were available for 6, of
which none were Mf-positive. The difference in proportion of Mf-positive results was not sta-
tistically significant, but sample sizes were small.
The number of years lived in American Samoa was not significantly associated with sero-
prevalence for antigen or antibodies. Antigen prevalence was 3.2% in those who had lived in
American Samoa since 2000 (when MDA started), 2.5% in those who arrived after 2006 (when
the last effective round of MDA was conducted), and 3.3% in those who arrived between
2000–2006 (Chi-squared test, p = 0.89). There were no significant differences in seroprevalence
between the three groups for Bm14 Ab (Chi-squared test, p = 0.25) or Wb123 Ab (Chi-squared
test, p = 0.65).
Fig 2. Population distribution, location of the two suspected hotspot areas, and the elementary school, clinic, and worksite surveyed in the
study. GIS data were provided by the American Samoa GIS user group [22].
https://doi.org/10.1371/journal.pntd.0005914.g002
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Age-adjusted seroprevalence of antigen and antibodies
Estimates of the seroprevalence of LF antigen (positive ICT and/or Og4C3 Ag>32 units),
Bm14 Ab, and Wb123 Ab were calculated, and adjusted for age based on the population age
distribution reported in the 2010 census [24]. Comparisons of the age-adjusted seroprevalence
for adult residents (aged15 years) of each suspected hotspot area and adult workers who
resided in other villages are summarised in Fig 5.
In adults who lived outside of hotspot villages, age-adjusted seroprevalence of LF antigen,
Bm14 Ab, and Wb123 Ab were 1.2% (95% CI 0.6–2.6%), 9.6% (95% CI 7.5%-12.3%), and
10.5% (95% CI 7.6–14.3%) respectively. Comparatively, adult residents of Fagali’i had signifi-
cantly higher seroprevalence of antigen (26.9%, 95% CI 17.3–39.4%), Bm14 Ab (43.4%, 95%
Fig 3. Residential locations of adult workers recruited from pre-employment clinic and tuna cannery (blue circles). GIS data were
provided by the American Samoa GIS user group [22].
https://doi.org/10.1371/journal.pntd.0005914.g003









Positive antigen (ICT and/
or Og4C3 >32 units)
% of population with
positive antigen (95% CI)
Residents of Ili’ili,
Vaitogi, and Futiga
418 7 6 4 10 2.4 (1.2–4.4)
Residents of Fagali’i 58 8 9 8 10 17.2 (8.6–29.4)
Adult workers living in
other villages
602 8 7 4 9 1.5 (0.7–2.8)
Total 1078 23 22 16 29 2.7 (1.8–3.8)
https://doi.org/10.1371/journal.pntd.0005914.t002
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CI 32.4–55.0%), and Wb123 Ab 55.2% (95% CI 39.6–69.8%) than adults living in other areas.
Adult residents of Ili’ili/Vaitogi/Futiga also had higher seroprevalence of antigen (4.0%, 95%
CI 1.8–8.8%), Bm14 Ab (12.5%, 95% CI 7.1–21.1%) and Wb123 Ab 18.5% (95% CI 11.4–
28.5%) than adults living in other areas, but the differences were not statistically significant.
Comparisons of the age-adjusted seroprevalence of antigen and antibodies in children
(aged 2 to 14 years) from each of the suspected hotspot areas are shown in Fig 6. Age-adjusted
seroprevalence of antigen and antibodies were higher in child residents of Fagali’i compared to
those who lived in Ili’ili/Vaitogi/Futiga: 5.0% (95% CI 0.7–29.5%) versus 1.3% (95% CI 0.5–
3.5%) for antigen; 30.0% (95% CI 13.8%-53.4%) versus 2.0% (95% CI 0.9–4.4%) for Bm14 Ab;
and 21.5% (95% CI 7.9–45.5%) versus 5.8% (95% CI 3.1–10.5%) for Wb123 Ab. The study did
not collect data from children in other villages that were sufficiently representative for mean-
ingful comparison with the results from suspected hotspots. It should be noted that for some
children, there were insufficient blood samples for all serological tests to be conducted. Wb123
Ab results were only available for 173 of the 305 (56.7%) children who lived in Ili’ili/Vaitogi/
Futiga, and 19 of the 20 (95%) children who lived in Fagali’i.
Association between presence of serological markers and place of
residence in adults
Odds ratios of the presence of antigens and antibodies in residents of suspected hotspot areas
were calculated using univariate logistic regression (weighted for age distribution), using adult
workers living in other villages as the reference group. Only participants aged15 years were
Fig 4. Age distribution of antigen-positive and microfilaraemic individuals (from all survey locations).
https://doi.org/10.1371/journal.pntd.0005914.g004
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included in this analysis because the reference group did not include any participants aged
<15 years. Table 3 shows that residents of both suspected hotspots were significantly more
likely to be seropositive. Residents of Fagali’i had significantly higher odds of being antigen
positive (OR 20.4 for ICT, OR 31.8 for Og4C3 Ag >32 units, and OR 23.5 for any antigen) and
antibody positive (OR 5.7 for Bm14 Ab and OR 9.5 for Wb123 Ab) than adult residents of
non-hotspot areas. Compared to this reference adult group, residents of Ili’ili/Vaitogi/Futiga
also had significantly higher odds of being positive for Og4C3 Ag of>32 units (OR 4.1) and
Wb123 Ab (OR 2.3), but not for ICT (OR1.6) or Bm14 Ab (OR 1.0).
Discussion
Our results confirm that adult residents of the two suspected hotspot areas were significantly
more likely to be seropositive for Og4C3 Ag and Wb123 Ab compared to adult residents of
other villages in American Samoa. Residents of Fagali’i were also significantly more likely to be
positive on ICT and seropositive for Bm14 Ab. We confirmed the presence of ongoing trans-
mission in the suspected hotspot areas by identifying microfilaraemic residents, including a
9-year-old child. The results of this study therefore support the previous findings of suspected
hotspots using a serum bank collected in 2010 for a leptospirosis study [19], and provide field
evidence that WHO’s recommendations for integrating LF surveillance activities with other
population-based surveys are potentially effective and feasible. However, the current study
Fig 5. Age-adjusted seroprevalence of antigen (ICT and/or Og4C3 Ag >32 units), Bm14 Ab, and Wb123 Ab in
adult residents of suspected hotspot areas and adult workers who lived in other villages.
https://doi.org/10.1371/journal.pntd.0005914.g005
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does not allow us to determine whether the hotspots represent areas of persistent transmission
that were not successfully interrupted by MDA, or newly formed hotspots after MDA was
completed.
Furthermore, our study confirmed ongoing transmission even though American Samoa
passed TAS-1 of 6 to 7 year old children in 2011–2012 [17] and again passed TAS-2 in 2015
[18] (conducted a few months after this study). Our findings suggest that testing adults is a
potentially effective surveillance strategy, particularly if performed in conjunction with TAS
and used as baseline data. However, this strategy might require a sampling scheme quite differ-
ent from the current WHO recommended sampling methods for TAS. In the post-MDA set-
ting, when overall prevalence is very low and typically even lower in young children, testing
adults might be more accurate for determining transmission status and more sensitive for
identifying hotspots.
The age-adjusted estimates of the prevalence of all serological markers were higher in adult
residents of Fagali’i compared to those who lived outside of hotspot villages. The seropreva-
lence of antigen and Wb123 Ab (but not Bm14 Ab) were higher in Ili’ili/Vaitogi/Futiga com-
pared to residents of non-hotspot villages, but differences were not statistically significant,
either because of the small sample size or the true absence of any difference. Although sero-
prevalence estimates for each group were standardised for age, the variations in age distribu-
tion between the groups could have made it more difficult to identify statistical differences.
Fig 6. Age-adjusted seroprevalence of antigen (ICT and/or Og4C3 Ag >32 units), Bm14 Ab, and Wb123 Ab in
child residents (aged 2–14 years) of suspected hotspot areas.
https://doi.org/10.1371/journal.pntd.0005914.g006
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Adult residents of both hotspots had significantly higher odds of being seropositive for
Og4C3 Ag and Wb123 Ab than residents of other (non-hotspot) areas. Adult residents of
Fagali’i also had higher odds of being seropositive for ICT and Bm14 Ab, compared to resi-
dents of other areas, but this was not found in Ili’ili/Vaitogi/Futiga. The reasons for the differ-
ences in the patterns of serological markers between the two hotspot areas are not clear, but
could potentially be attributed to differences in intensity of transmission; or the timing of pos-
sible reintroduction or resurgence; or differences between persistent transmission from before
MDA versus reintroduction or resurgence. The age-adjusted estimates of overall seropreva-
lence of all antigens and antibodies were significantly higher in Fagali’i compared to Ili’ili/Vai-
togi/Futiga, suggesting higher transmission intensity in Fagali’i both recently and in the past.
Previous studies in children have demonstrated the appearance of antigen and Wb123 Ab ear-
lier in the course of infection than Bm14 Ab [27]. In Ili’Ili/Vaitogi/Futiga, the higher odds of
being seropositive to antigen and Wb123 Ab (but not Bm14 Ab), together with ICT-positive
6–7 year olds in the local school in both TAS-1 and TAS-2, might reflect more recent reintro-
duction and/or resurgence compared to Fagali’i.
Our previous study found that recent migrants to American Samoa (mostly from Samoa)
had significantly higher antigen and antibody prevalence [19], but this study did not find any
significant difference in seroprevalence and number of years lived in American Samoa. A pos-
sible explanation is that more time has lapsed since MDA, and there is less difference in infec-
tion risk and/or the impact of MDA between long-term residents and recent migrants.
The strengths of our study include the large proportion of the population tested in the hot-
spot areas as well as the general population, and the wide range of age groups included. Our
study population was highly stable and allowed accurate assessment of geographic variations
in risk; >70% of each group had lived in American Samoa since the PacELF programme com-
menced in 2000. Our results should also be considered in light of the study’s limitations.
Because of financial constraints and limited resources, the study was conducted using
Table 3. Odds ratios for presence of serological markers for adult residents of hotspot villages compared to adult workers living in other villages
(adjusted for age).
Presence of serological markers Groups Number tested Number positive (%) OddsRatio (OR) p value
ICT Residents of Fagali’i 38 7 (18.4) 20.4 <0.001
Residents of Ili’ili/Vaitogi/Futiga 113 3 (2.7) 1.6 0.539
Adult workers living in other villages 602 8 (1.3) 1
Og4C3 Ag >128 Residents of Fagali’i 38 7 (18.4) 51.9 <0.001
Residents of Ili’ili/Vaitogi/Futiga 112 4 (3.6) 5.2 0.023
Adult workers living in other villages 598 4 (0.7) 1
Og4C3 Ag >32 Residents of Fagali’i 38 8 (21.1) 31.8 <0.001
Residents of Ili’ili/Vaitogi/Futiga 112 6 (5.4) 4.1 0.016
Adult workers living in other villages 598 7 (1.2) 1
Antigen positive (ICT and/or Og4C3 Ag >32 Residents of Fagali’i 38 9 (23.7) 23.5 <0.001
Residents of Ili’ili/Vaitogi/Futiga 113 6 (5.3) 2.6 0.098
Adult workers living in other villages 602 9 (1.5) 1
Bm14 Ab Residents of Fagali’i 38 17 (44.7) 5.7 <0.001
Residents of Ili’ili/Vaitogi/Futiga 112 15 (13.4) 1.0 0.931
Adult workers living in other villages 598 70 (11.7) 1
Wb123 Ab Residents of Fagali’i 38 20 (52.6) 9.5 <0.001
Residents of Ili’ili/Vaitogi/Futiga 112 22 (19.6) 2.3 0.014
Adult workers living in other villages 598 65 (10.9) 1
https://doi.org/10.1371/journal.pntd.0005914.t003
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convenience sampling instead of probability-based sampling. Our reference group (adult
workers who lived in other villages) were over 15 years of age but children were included in
the residents of hotspot areas. Our previous study found that recent migrants who had not
lived in American Samoa from the beginning of PacELF were more likely to be seropositive for
antigen and antibody [19]. A lower proportion of our reference group (70.7%, 95% CI 66.8–
74.3%) had lived in American Samoa since the beginning of PacELF compared to residents of
Fagali’i (75.7%, 58.8–88.2%) and residents of Ili’ili/Vaitogi/Futiga (75.7%, 95% CI 66.6–83.3%).
Our study only considered the place of residence, but infection could have occurred at work or
elsewhere, especially when efficient day biters are present. Each of these three limitations could
have weakened the associations between living in a hotspot and the presence of serological
markers, but our study found statistically significant results despite the limitations. The age
distributions of the hotspot residents and adult workers were significantly different to that of
the general population, but the estimates of population seroprevalence were adjusted for age.
Convenience sampling of hotspot residents and adult workers might have introduced bias
towards people who have been diagnosed with LF, concerned that they might have the infec-
tion, or previously taken MDA. However, there was no evidence that any biases related to pre-
vious MDA or LF diagnosis were different between hotspot residents and adult workers.
Our findings raise a number of questions regarding current guidelines and targets used in
LF elimination programmes, strategies for post-MDA surveillance, and transmission dynamics
in the post-MDA setting. Firstly, our findings indicate that the current WHO recommended
TAS has limitations in detecting ongoing transmission in the American Samoa setting. Our
current study and previous studies in American Samoa [10,19] found evidence of ongoing
transmission despite the territory passing TAS-1 in 2010/2011 and TAS-2 in 2015. In Ameri-
can Samoa, the antigen prevalence threshold used in school-based TAS of young children was
not sensitive enough to detect ongoing low-level transmission. Future post-MDA surveillance
strategies should consider including older children and adults, and/or determining thresholds
that are more specific for different ecological settings [28]. In areas with highly efficient vectors
(such as Ae. polynesiensis in American Samoa), LF transmission is likely to be more intense,
and might therefore require different elimination targets to successfully interrupt transmis-
sion. Furthermore, TAS in American Samoa did not provide any indication of the high antigen
prevalence in the Fagali’i hotspot even though >90% of elementary schools were included in
the surveys. Our study identified heterogeneity in LF transmission at very small spatial scales,
and concur with findings from diverse settings including Samoa [29], Haiti [30], Sri Lanka
[31], and Zanzibar [32]. Our results also corroborate findings from Sri Lanka that TAS might
not be sensitive enough for identifying small hotspots [31]. However, it is currently unclear
whether these small residual foci of transmission will pose any significant risk of resurgence in
the broader community, but the presence of microfilaraemic young children in these hotspots
suggest that transmission is unlikely to disappear without intervention, particularly in areas
with highly efficient vectors and strong environmental drivers of transmission.
Secondly, our findings raise concerns that in some settings, seven annual rounds of MDA
might not be sufficient for interrupting transmission. Persistent transmission has been noted
in Ghana [33] after up to 11 rounds of annual MDA, particularly in areas with high baseline
Mf prevalence. In Zanzibar, ongoing transmission was detected six years after MDA, despite
good coverage rates and Mf prevalence of<1% at sentinel sites after five rounds of MDA [32].
Thirdly, our results suggest that ICT might not be as sensitive as Og4C3 Ag or Wb123 Ab
for detecting low-level transmission or resurgence, such as our hotspot in Ili’ili/Vaitogi/Futiga
where Og4C3 Ag and Wb123 Ab provided warning signals, but ICT did not. In Mali, where
MDA was conducted from 2002 to 2007, surveys in children in six formerly highly endemic
villages found that ICT prevalence decreased from 53% pre-MDA to 0% (N = 120) after 6
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rounds of MDA, and all adults tested in these villages were also antigen negative (N = 686)
[34]. However, other longitudinal surveys in these villages using Og4C3 Ag and Wb123 Ab
showed an increasing trend of antigen and antibody positivity in 6–7 year old children, from
0% in 2009 to 2.7% in 2011 and 4.5% in 2013, with one and three Mf positive children in 2009
and 2011 respectively [35]. Paradoxically, antigen prevalence by ICT in older children (>8
years) and adults decreased from 4.9% in 2009 to 2.8% in 2012. The results suggest that Og4C3
Ag and Wb123 Ab were more sensitive than ICT, and also raise the suggestion that in formerly
highly endemic areas, adults might be immunologically protected while young children are
susceptible and more rapidly infected.
Further research is being conducted in American Samoa to improve understanding of LF
transmission in the post-MDA setting by conducting more representative sampling of all age
groups in the general population, comparing the sensitivity of school-based versus commu-
nity-based surveys, identifying risk factors for infection including the role of migrants, deter-
mining the spatial distribution and clustering of infected persons, and exploring the use of
molecular xenomonitoring of mosquitoes.
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